Glycerol kinase (GK) is at the interface of fat and carbohydrate metabolism and has been implicated in insulin resistance and type 2 diabetes mellitus. To define GK's role in insulin resistance, we examined gene expression in brown adipose tissue in a glycerol kinase knockout (KO) mouse model using microarray analysis. Global gene expression profiles of KO mice were distinct from wild type with 668 differentially expressed genes. These include genes involved in lipid metabolism, carbohydrate metabolism, insulin signaling, and insulin resistance. Real-time polymerase chain reaction analysis confirmed the differential expression of selected genes involved in lipid and carbohydrate metabolism. PathwayAssist analysis confirmed direct and indirect connections between glycerol kinase and genes in lipid metabolism, carbohydrate metabolism, insulin signaling, and insulin resistance. Network component analysis (NCA) showed that the transcription factors (TFs) PPAR-c, SREBP-1, SREBP-2, STAT3, STAT5, SP1, CEBPa, CREB, GR and PPAR-a have altered activity in the KO mice. NCA also revealed the individual contribution of these TFs on the expression of genes altered in the microarray data. This study elucidates the complex network of glycerol kinase and further confirms a possible role for glycerol kinase deficiency, a simple Mendelian disorder, in insulin resistance, and type 2 diabetes mellitus, a common complex genetic disorder.
simple Mendelian disorders complex traits and that this complexity is due to the role of modifier genes, metabolic flux through related pathways, systems dynamics, thresholds of protein functions, networks that the protein functions within as well as the moonlighting (alternative) functions of the enzyme. 2 -5 There is an emerging role for GK in type 2 diabetes mellitus (T2DM) as individuals with a GK missense mutation, N288D, have the asymptomatic form of isolated GKD, increased risk for obesity, insulin resistance and T2DM. 6 In addition, hepatocyte nuclear factor 4 alpha (HNF4a) is important for GK expression 7 and mutations in HNF4a are associated with maturity onset diabetes of youth (MODY). 8 HNF4a is an orphan nuclear receptor involved in regulating gluconeogenesis in the liver, 9 insulin secretion, and directly activates the insulin gene. 10, 11 Recently many studies have focused on the role of HNF4a variants and polymorphisms on T2DM. 12 -17 Thiazolidinediones (TZDs)
are drugs used to treat T2DM 18 and have been shown to induce GK expression in adipocytes, which reduces free fatty acid (FA) secretion and increases insulin sensitivity. 19, 20 Insulin resistance and T2DM results from a network of interactions between many genes and environmental factors. 21 Identification of these interactions will allow a better understanding of the molecular mechanisms leading to insulin resistance and T2DM. GK is not normally expressed in white adipocytes but it is induced by TZD's in this tissue. 22 However, GK is expressed in brown adipose tissue (BAT) which is metabolically active. 23 BAT expresses LPL (lipoprotein lipase) which releases FA from lipoproteins and increases FA uptake. TZDs also affect BAT 24, 25 and decreased BAT activity is associated with obesity, insulin resistance, and hyperlipidemia. 26 Maintenance of adequate stores of TAG, through esterification of G3P is essential for BAT functioning. 27 In addition, insulin deficiency induces BAT glyceroneogenesis to produce more G3P which is important to preserve the normal metabolic activity of BAT. Therefore, we hypothesize that GK has a role in BAT energy homeostasis and insulin resistance.
To relate gene expression data to protein function, we used network component analysis (NCA) which reduces dimensionality of high-dimensional microarray data to a lower dimension. 28, 29 This allows identification of hidden dynamics and patterns such as transcription factor activities, (TFAs) which may not be found by microarray analysis.
In this study, we investigated the role of the murine ortholog of GK, Gyk, in metabolism (fat and carbohydrate), and insulin sensitivity using microarray analysis of BAT from wild-type (WT) and Gyk knockout (KO) mice. We determined that Gyk deletion causes alterations in expression of genes involved in carbohydrate and lipid metabolism as well as insulin signaling. NCA determined Gyk's role in adipocyte-specific transcription. Our work confirms a role for GK in metabolism and insulin resistance and helps to understand the complexity of this single gene disorder.
Materials and methods

Animal care
Gyk-deficient mice (courtesy of W J Craigen, Baylor College of Medicine) were generated using 129/SvJ embryonic stem cells, bred to a C57B1/6J mouse, and then backcrossed onto C57B1/6J to make a congenic strain on C57B1/6J. 30 WT controls are male littermates of the KO mice and were born to carrier mothers. The mice were on a normal 3.5% fat diet (Harlan Tekland) and experiments were per a UCLA Chancellor's Animal Research Committee approved protocol.
RNA isolation
Day three of life WT and Gyk KO mice in the fed state were killed and interscapular BAT was extracted, homogenized in Trizol reagent (GibcoBRL Life Technologies, Rockville, MD, USA), frozen in liquid nitrogen, and stored at À801C. Three to five tissues were pooled, then RNA was isolated (Trizol reagent, Gibco BRL Life Technologies), purified (RNeasy minielute, Qiagen, Valencia, CA, USA), and DNase treated (Turbo DNA-free, Ambion Inc., Austin, TX, USA).
cDNA synthesis and hybridization cDNA synthesis was performed on pooled RNA and hybridized to Affymetrix Mouse Genome 430 2.0. Gene chips (three WT and four KO) as described. 31 
Microarray analysis
Microarray data was analyzed using DNA-Chip (dChip) analyzer software. 32 Two unsupervised learning methods (multidimensional scaling and hierarchical clustering with an Euclidean distance measure) were used on genes with a coefficient of variance between 0.3 and 10, and a percent present call of 20% to define the 'most varying probesets' (3776 probesets). Differentially expressed genes were filtered out using the criteria: fold change 41.5 between baseline (WT) and experimental (KO), absolute difference in the expression level between WT and KO 4100, Student's t-test P-value o0.05, and percent present call of X20%.
Gene annotation
Genes that met the above criteria were used to identify enriched biological themes by Expression Analysis Systemic Explorer (EASE) 33 using the categorical overrepresentation function and the one-tailed Fisher exact probability for overrepresentation.
Real-time polymerase chain reaction RNA was extracted as described above. KO and WT samples included some of the samples from microarray analysis as well as single animal samples. Gene expression assays (Applied Biosystems Inc. (ABI), Foster City, CA, USA) were used for all genes. Predeveloped Taqman assay reagents for 18 s rRNA (ABI) were the endogenous controls. cDNA synthesis was performed using Superscript III (Invitrogen Corp., Carlsbad, CA, USA) per the manufacturer's instructions with random primers. The reaction was carried out using Taqman master mix (ABI) and Real-time polymerase chain reaction (RT-PCR) products detected using ABI prism 7700/7500 Sequence detection system. Fold differences for each of the genes were calculated using the 2 ÀDDC T method. 34 
PathwayAssist analysis
Altered genes were analyzed using PathwayAssist (version 3.0,. Stratagene, La Jolla, CA, USA) by searching for connections of the genes listed in Tables 1 and 2 by looking for common regulators, and finding the shortest paths between nodes.
NCA PUBMED was used to construct the connectivity matrices between transcription factors (TFs) important in adipocytes and genes differentially expressed in the microarray analysis. NCA was performed with criteria of 1.2-fold change, absolute difference in the expression level between the WT and KO larger than 100, Student's t-test P-value o0.05, and percent present call X20%. Ten TF were used to construct the final connectivity matrix. The data matrices were decomposed and the control strengths (CS), and transcription factor activity (TFA) matrices and contribution plots were obtained using the NCA toolbox (http:// www.seas.ucla.edu/~liaoj/downloads/htm).
Results
Three-day-old mice were chosen for this study because this is the first day that the mice have statistically significant clinical symptoms including hypoglycemia, lower pH, lower bicarbonate, and lower base excess, which mimics the human disease. 35 It was felt that on day of life two the important changes from glycerol kinase deficiency would not be present without the clinical changes seen in mice (and humans). We believe that the majority of the changes seen on day 3 will be owing to the effects of GKD, however one cannot rule out the possibility that some will be due to the perimortum state of the mice as they die on DOL4.
Measurements of the brown fat pads in subsequent WT and KO mice have shown no statistical difference in weight (in g) (data not shown).
Unsupervised hierarchical clustering and multidimensional scaling using the 3776 most varying probesets showed that the gene expression in BAT in a Gyk KO mouse model grouped together according to KO and WT status (Figures 1a and b) . In both the hierarchical clustering tree ( Figure 1a ) and the multidimensional scaling ( Figure 1b ) the bfko2 sample is linked to the WT samples however, it is still distinct from them. This unsupervised learning analysis demonstrates that Gyk KO mice have a distinct global gene expression profile compared to WT. Differential gene expression analysis (gene filtering) 
Sulfotransferase family 1A, member 1 AK002700
Sphingosine phosphate lyase 1 NM_009163 1.9 (1.4, 2.6) Zap128
Cytosolic acyl-CoA thioesterase 1 NM_012006
The numbers in parentheses represent the lower and upper limits of the fold change. Student's t-test P-value o0.05. The numbers in parentheses represent the lower and upper limits of the fold change.
Glycerol kinase deficiency alters gene expression L Rahib et al (Adipor1) ( Table 2A) . Twelve genes involved in carbohydrate metabolism were differentially expressed (excluding Gyk); eight of which were downregulated including glycogen synthase 2 (Gys2), alpha-N-acetylglucosaminidase (Naglu), and pyruvate dehydrogenase beta (Table 2B) . Four genes were upregulated including sorbitol dehydrogenase 1 (Table 2B) .
To assess GK's role in insulin resistance and T2DM, we examined the differential gene expression of genes involved in insulin sensitivity including genes encoding insulin-receptor-associated proteins, components of and downstream effectors of the phosphatidylinositol 3-kinase (PI3K) and MAP kinase pathways, primary target genes for insulin resistance, effectors of insulin signaling, and target genes for peroxisome proliferator-activated receptor gamma (PPAR-g). We found 25 probesets (19 genes) that were differentially expressed between KO and WT mice ( Table 3 ) that relate to insulin signaling or insulin resistance.
Ten probesets (7 genes) were downregulated including insulin-like growth factor 1 (Igf1), eukaryotic translation initiation factor 4E (Eif4e), sterol regulatory element binding factor 2 (Srebf2), leptin (Lep), jun oncogene (Jun), mitogenactivated protein kinase 6, and Fasn. Fifteen probesets (12 genes) were upregulated in the Gyk KO mouse including adrenergic receptor beta 1 and 3 (Adrb1 and Adrb3), CCAAAT/enhancer binding protein delta (Cebpd), and insulin-like growth factor binding protein 3 (Igfbp3).
Supervised hierarchical clustering based on the 28 and 12 differentially expressed genes (29 and 13 probesets) belonging to lipid and carbohydrate metabolism, respectively showed a clustering distinction between WT and KO mice (Figure 2a) . The 19 genes (25 probesets) differentially expressed involved in insulin signaling and insulin resistance also showed distinct clustering of the WT and KO mice (Figure 2b ). a b Figure 2 Supervised hierarchical clustering of KO and WT samples; (a) dChip clustering tree of top 46 most significant differentially expressed probesets involved in lipid and carbohydrate metabolism. (b) dChip clustering tree of top 25 most significant differentially expressed probesets involved in insulin signaling and insulin resistance. The top genes for both clusters were filtered out using fold change larger than 1.5, absolute difference in the expression level larger than 100, Student's t-test P-value smaller than 0.05, and percent present call of at least 20%. bfko represents brown fat knockout and bfmwt represent brown fat male wild type.
Glycerol kinase deficiency alters gene expression L Rahib et al
RT-PCR was performed on 30 genes found to be differentially expressed by microarray analysis. RT-PCR confirmed 20 of these 30 genes including the downregulation of carbohydrate and lipid metabolism genes including Gyk, Gys2, Naglu, and galactose-4-epimerase (Gale) (Figure 3 and Table 4 ). Sphingosine phosphate (Sgpl1), Lpin1, sulfotransferase family 1A, phenol-preferring, member 1 (Sult1a1), and flavin containing monooxygenase 1 (Fmo1) were upregulated in the KO mice by both RT-PCR and microarray expression data ( Figure 3 and Table 4 ).
PathwayAssist analysis was used to represent the networks affected by Gyk deletion (Figure 4) . Genes involved in lipid and carbohydrate metabolism, insulin signaling, and insulin resistance that were found to be altered in the microarray were used to create the pathway. For example, Gyk deletions lead to disruption of genes such as leptin that is implicated in insulin resistance. Central regulators in the pathway include PPAR-g, PPAR-a, jun oncogene (JUN), tumor necrosis factor (TNF), glucose, and glucocorticoid. JUN is the most highly connected node, which likely reflects its global role as a transcription factor and it's involvement in a wide variety of biological processes. 36 -39 We elucidated transcription factor activities of TFs important in adipose tissue in the absence of Gyk using NCA of our microarray data as described in methods. Sixtyseven genes and 10 TFs resulted from the analysis. PPAR-g, trans-acting transcription factor 1 (SP1), CCAAT/enhancer binding protein alpha, and glucocorticoid receptor (GR) activities were increased in the KO compared to the WT ( Figure 5 ) whereas SREBP-2, SREBP-1, signal transducer and activator of transcription 3 (STAT3), STAT5, cAMP responsive element binding protein 1 (CREB), and PPAR-a activities were decreased in the KO ( Figure 5 ). The connectivity, CS, expression matrices, and references used to deduce TFA and control strengths (CS) are provided as supplemental material. In order to rule out false discovery, we performed 100 permutations by shuffling the gene expression data and tested for significance. All activities of the 10 TFs showed perturbations when compared to the 100 permutated (shuffled gene expression) data (P-value o0.05) (data not shown). Contribution plots for phosphogluconate dehydrogenase (Pgd), angiopoietin-like 4 (Angptl4), fatty acid binding protein 4, adipocyte (Fabp4), Cebpd, Fasn, solute carrier family 2 (facilitated glucose transporter) member 3 (Slc2a3), insulin-like growth factor 1 receptor (Igf1r), and Igf1 are depicted in Figure 6 . The graph shows the contribution to the total gene expression of the specific gene by each TF (hatched and white bars each represent a TF) and the actual gene expression from the microarray data is represented by black bars.
Discussion
We report gene expression profiles in the Gyk KO mouse to provide insights into the role of GK in brown fat, insulin resistance, and T2DM. The Gyk KO mouse model mimics human GKD in that the mice have hyperglycerolemia, metabolic acidosis, and hypoglycemia. 30, 35 However, the Gyk KO mouse has a more severe phenotype as the mice have growth retardation and die in the neonatal period.
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Of the biological themes identified using EASE analysis, cell proliferation was the most highly enriched (P-value o0.0001). Two related biological themes, regulation of cell proliferation (P-value o0.001) and negative regulation of cell proliferation (P-value ¼ 0.01), were also significantly enriched in the KO mouse. This may relate to the emerging role of GK in apoptosis 40 and energy metabolism at the outer mitochondrial membrane. 41 GK binds to the voltage dependent anion channel (VDAC or porin) of the outer mitochondrial membrane, 41, 42 a component of the Figure 3 RT-PCR data (mean7SEM) expressed as relative mRNA levels of Gyk KO compared to WT mice. Glycerol kinase (Gyk) (n ¼ 4),
, and Fmo1 (n ¼ 4). *Po0.01, ** Po0.05. Glycerol kinase deficiency alters gene expression L Rahib et al mitochondrial permeability transition pore complex (PTPC) involved in cytochrome c release and apoptosis. 41, 43 A large number of enriched biological themes were identified in the Gyk KO mouse (Table 1) . This attests to the complex biological network, within which GK is functioning and may be due in part to its role in phosphorylating glycerol. Of particular interest is carbohydrate and lipid metabolism, which we focused on for further analysis.
Within the category of carbohydrate metabolism, the levels of Gys2 were downregulated in the KO mice. Glycogen synthase (GYS) is expressed in the liver, catalyzes the incorporation of a glycosyl residue into glycogen, and is regulated by insulin, glucose, and glucose-6-phosphate. 44, 45 In the absence of GK, the cell may become more dependent upon glucose metabolism to drive cellular processes. Therefore, glucose will not be converted into glycogen and a reduction of glycogen synthase would be expected.
In the lipid metabolism group, Lpin1, involved in fat adipocyte differentiation, is upregulated in the Gyk KO, whereas Lip1, involved FA release, is downregulated. LIP1 catalyzes hydrolysis of cholesteryl esters and triglycerides, and is suppressed by insulin. 46 These findings suggest that GK deletion possibly stimulates adipocyte differentiation and decreases fat hydrolysis. The stimulation of adipocyte differentiation is intriguing given the role of PPAR-g in adipocyte differentiation and stimulation of Gyk expression. 19, 20 The levels of PPAR-g mRNA were not changed in Figure 4 PathwayAssist analysis involving differentially expressed genes from carbohydrate and lipid metabolism groups and from the insulin signaling and insulin resistance groups. Black nodes represent proteins coded by genes upregulated in the microarray analysis, gray nodes represent proteins coded by genes that were downregulated, and white nodes represents no change in the micorarray. Ovals represent genes involved in lipid and carbohydrate metabolism, hexagons represent genes involved in insulin and insulin resistance, rectangles represent genes that belong to both groups, diamonds represent common regulators of the differentially expressed genes, and octagonal nodes represent small molecules. Gyk is denoted by a triangle. ABCD2, ATP-binding cassette subfamily D member 2; ACACB, acetyl-Coenzyme A carboxylase beta; ADIPOR1, ADRB1, adrenergic receptor beta 1; ADRB3, adrenergic receptor beta 3; CEBPA, CCAAT/enhancer binding protein, alpha; CEBPD, CCAAT/enhancer binding protein delta; CEBPG, CCAAT/enhancer binding protein gamma; CITED2, Cbp/p300-interacting transactivator 2; CSF2, colony-stimulating factor 2; PRKCM, DGAT2, diacylglycerol O-acyltransferase 2; EIF4E, FDFT1, farnesyl diphosphate farnesyl transferase 1; GALE, galactose-4-epimerase, UDP; GH1, growth hormone 1; Glut1, glucose transporter 1; GC, glucocorticoid; GYS2, glycogen synthase 2; HPGD, hydroxyprostaglandin dehydrogenase 15; IFNG, interferon gamma; IGF1, insulin-like growth factor 1; IGFBP3, insulin-like growth factor binding protein 3; IL1B, interleukin 1 beta; IL1F8, interleukin 1 family, member 8; IL4, interleukin 4; IL5, interleukin 5; IL9, interleukin 9; INS, insulin; JUN, jun Oncogene; Lep, leptin; LIPA, lipaseA; LRPAP1, lipoprotein receptor-associated protein; LTC4S, leukotriene C4 synthase; NEU1, sialidase 1; NF kB1, nuclear factor kappa-B, subunit 1; PLAA, phospholipase A2-activating protein; PLCD3, phospholipase C, delta 3; PLD2, phospholipase d2; PPARA, peroxisome proliferator-activated receptor alpha; PPARG, peroxisome proliferator-activated receptor gamma; PRKCM, protein kinase C, mu; PTPN11, protein tyrosine phosphatase non-receptor type 11; SLC35A2, solute carrier family 35, member 2; SORD, sorbital dehydrogenase; SP1, sp1 transcription factor; SREBF2; SULT1a1, sulfotransferase family 1A; TCF1, transcription factor 1; TNF, VLDLR.
the Gyk KO mice compared to the WT, although PPAR-g is activated as determined by NCA thus demonstrating the importance of NCA. These studies suggest that GK has a role in adipocyte differentiation and may relate to its role in T2DM.
Differentially expressed genes involved in insulin signaling, insulin resistance, and T2DM identify a link between GK and T2DM. Phospholipase d2 (Pld2) and protein kinase C (Pkc) mRNA levels were upregulated in Gyk KO mice 2.3-and 1.5-fold respectively. PLD2 releases diacylglycerol (DAG) during the breakdown of phospholipids. DAG is involved in many different signal transduction pathways including the activation of PKC, 47 which ultimately inhibits insulin action in muscle. 48 -50 The increase of PLD2 and PKC in the absence of GK suggests that the presence of GK is important for maintaining normal insulin action, which is consistent with insulin resistance in individuals with GKD. The pathways affected by GK deletion were examined (Figure 4) . Pathway Assist analysis showed that JUN was the node with the highest connectivity. This is possibly due to the increase of leptin in the KO mice because leptin increases JUN transcriptional activity. 51 JUN's central role is likely due to its extensive role as a transcription factor in numerous mechanisms. 36 -39 SP1 was implicated to regulate five of the genes that were altered by Gyk deletions: Lep, Adrb1, solute carrier family 2 (facilitated glucose transporter) (Slc2a1), member 1, Jun, and leukotriene C4 synthase. This confirms SP1's role as a key mediator of 'cross-talk' between signaling pathways such as insulin sensitivity, and gene transcription. 52 Although SP1 regulates genes that are affected by GK deletions, the direct role of GK on SP1 remains unknown. Insulin was also implicated in the regulation of five of the genes differentially expressed in the microarray: Adrb3, Pld2, Dgat2, Gys2, and Lip1. Other key regulators in the pathway include PPAR-g, PPAR-a, glucose, glucocorticoid, and TNF. PathwayAssist analysis provides a better understanding of the complexity of the network that GK functions in and suggests that GK is a critical component in multiple pathways. NCA determined the TFA of TFs important in BAT when GK is deleted including PPAR-g, SREBP-1, SREBP-2, STAT3, STAT5, SP1, CEBPa, CREB, GR, and PPAR-a. The gene expression level of Srebf2, which codes for SREBP-2 was significantly decreased in the KO mice vs the WT mice (1.86-fold). All other TFs gene expression levels were not significantly altered. This variance of gene expression level and TFA shows the importance of NCA to determine TF protein function from gene expression data.
A total of 12 PPAR-g target genes were altered in our microarray data including Angptl4 and Adipor1, which are both upregulated. Angptl4 has been shown to be upregulated during fasting. 53 GKD is similar to fasting in that glycerol and FA are released. Fasn, uncoupling protein 3 (Ucp3), and Dgat2 are downregulated in the KO mice. Fasn is involved in FA synthesis and is probably decreased in the KO as a feedback response by the cells to compensate for the absence of GK, which blocks the esterification of FA. Dgat2 is responsible for the synthesis of triglycerides and needs G3P. 54 We would predict TFs such as PPAR-g involved in adipocyte differentiation to be altered in the KO mice as the cells attempt to compensate for the lack of triglyceride synthesis by activating adipocyte differentiation. Aquaporin 7 (Aqp7), a PPAR-g target gene, functions to transport glycerol into the blood stream when needed.
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Aqp7 is decreased in the KO mice, which is intriguing, as previous studies have shown that Aqp7 disruption leads to increased GK levels in adipocytes. 56 The studies show that
Aqp7 deficiency leads to obesity by increasing GK levels. The decrease in Aqp7 in the Gyk KO mice is most likely in response to the excess glycerol in the bloodstream (hyperglycerolemia). Therefore, glycerol does not need to be transported into the bloodstream and Aqp7 is not expressed.
We assessed the relative contributions of various TFs on specific gene expression. The expression of Slc2a3, a glucose transporter gene is increased in the Gyk KO mice. Slc2a3 gene expression is controlled by SP1 (inhibitor) and CREB (activator). The actual levels of Slc2a3 expression are higher in the KO because the activation of Slc2a3 by CREB is greater than the inhibition by SP1 (Figure 6 ). Fabp4 gene expression is increased in the Gyk KO mouse owing to the activation by both PPAR-g and CEBP-a ( Figure 6 ). Fasn encodes Fasn, which catalyzes the synthesis of palmitate from acetyl-CoA and malonyl-CoA into long-chain saturated FA. PPAR-g antagonizes SREBP-1 to contribute to an overall decrease of Fasn gene expression ( Figure 6 ). For all of the TFA, the fitted expression represented by the contributions of the TFs (hatched and white bars) correlated with the actual expression from the microarray data (represented by the black bars). This study confirms and expands our previous work indicating that NCA can be used in mammalian systems 31 and allows better definition of the transcriptional network within which GK functions. This study confirmed that GK has an integral part in the overall metabolic network including insulin signaling and begins to elucidate the relationship between GKD, insulin resistance, and T2DM. Specifically, our study showed that GK deletion causes alterations in gene expression levels of genes involved in lipid and carbohydrate metabolism, as well as other metabolic and transcriptional networks including genes involved in insulin resistance. Further investigations into the mechanisms of these alterations may provide greater insight into the links between glycerol and glucose metabolism, and the role of GK in insulin resistance and T2DM. Such investigations will help us understand the complexity of GKD and serve as a model for other complex genetic diseases.
